EMJ-30429-59928
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 322 / FL
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Ocular hyperaemia, Periorbital swelling — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Puffy eyes/red eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-19
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
-
2021-01-01
Survey response — day 14, dose 1MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Got a cold. Covid test was negative.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-24
- 2021-01-29
- 2021-02-05
-
2021-07-09
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had covid 19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-12
- 2021-07-15
-
2021-09-10
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-03
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-12-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-10 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Puffy eyes/red eyes
Release 1 — day 14, dose 1
Symptoms: Got a cold. Covid test was negative.
Release 9 — 6 months, dose 2
Symptoms: Had covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SRO | Periorbital swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release